Status not kept up to date
A Clinical Study for the Pan-vascular Interventional Robotic System
NCT06110988 · Shenzhen Institute of Advanced Biomedical Robot Co., Ltd. · Updated 26 April 2024
- What is being tested
- Pan-vascular interventional robotic system
- For
- Percutaneous Coronary Intervention; Pan-vascular Interventional Robotic System
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 5 people. The full rules are on the registry page.
- Where
- China (2 sites)
- When
- Starts or started 30 April 2024, ends 30 Sept 2024. Registered 1 Nov 2023.
- Results
- None posted yet.
In the researchers' words
The goal of this prospective, single-center, single-arm study is to explore the efficacy and safety of the pan-vascular interventional robotic system for percutaneous coronary intervention (PCI), researchers will assess the clinical success, technical success, and record the intraoperative data (PCI time, guidewire operation time, dose of contrast medium, radiation exposure doses, etc). All subjects will be followed up on the day of surgery, before discharge (or 48 hours after surgery) and 1 month after surgery to observe the safety indicators.
Sites
- Shanghai Zhongshan HospitalShanghai, Shanghai Municipality, China
- Kashi Prefecture Second People's HospitalKashgar, Xinjiang, China